Nanjing Well Pharmaceutical Co Ltd Strategic Asset Allocation Index
Nanjing Well Pharmaceutical Co Ltd strategic asset allocation index. Nanjing Well Pharmaceutical Co Ltd (603351) has a Strategic Asset Allocation Index of 99.4% as of June 2023. Strategic assets (PP&E of CN¥1.51 Billion plus long-term investments of CN¥-) total CN¥1.51 Billion, measured against net assets of CN¥1.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Nanjing Well Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Nanjing Well Pharmaceutical Co Ltd (2016–2022)
Strategic asset allocation index of Nanjing Well Pharmaceutical Co Ltd from 2016 to 2022. This chart shows how Nanjing Well Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 99.4%, representing strategic assets of CN¥1.51 Billion against net assets of CN¥1.52 Billion CNY. Check Nanjing Well Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Nanjing Well Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2022)
Nanjing Well Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Well Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Nanjing Well Pharmaceutical Co Ltd (603351) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 100.0% | CN¥1.48 Billion | CN¥1.48 Billion | CN¥- | CN¥1.48 Billion | ▲ +12.5 pp |
| 2021 | 87.5% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥1.39 Billion | ▲ +15.1 pp |
| 2020 | 72.4% | CN¥940.80 Million | CN¥940.80 Million | CN¥- | CN¥1.30 Billion | ▲ +32.1 pp |
| 2019 | 40.3% | CN¥500.65 Million | CN¥500.65 Million | CN¥- | CN¥1.24 Billion | ▼ -19.8 pp |
| 2018 | 60.1% | CN¥369.32 Million | CN¥369.32 Million | CN¥- | CN¥614.61 Million | ▲ +2.8 pp |
| 2017 | 57.3% | CN¥305.30 Million | CN¥305.30 Million | CN¥- | CN¥532.80 Million | ▲ +4.4 pp |
| 2016 | 52.9% | CN¥234.80 Million | CN¥234.80 Million | CN¥- | CN¥443.99 Million | — |